Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$129K Sell
466
-204
-30% -$57.6K 0.06% 153
2026
Q1
$179K Buy
670
+35
+6% +$9.68K 0.04% 235
2025
Q4
$175K Sell
635
-106
-14% -$29.7K 0.04% 235
2025
Q3
$214K Sell
741
-12
-2% -$3.55K 0.05% 215
2025
Q2
$249K Hold
753
0.06% 186
2025
Q1
$248K Buy
753
+4
+0.5% +$1.21K 0.07% 175
2024
Q4
$207K Buy
749
+17
+2% +$5.42K 0.06% 200
2024
Q3
$254K Buy
732
+8
+1% +$2.75K 0.07% 178
2024
Q2
$239K Sell
724
-112
-13% -$38.6K 0.08% 167
2024
Q1
$304K Sell
836
-15
-2% -$4.94K 0.1% 141
2023
Q4
$255K Buy
851
+588
+224% +$172K 0.1% 144
2023
Q3
$75.2K Sell
263
-35
-12% -$9.98K 0.04% 279
2023
Q2
$83.6K Sell
298
-9
-3% -$2.34K 0.04% 263
2023
Q1
$78.4K Hold
307
0.04% 249
2022
Q4
$102K Buy
307
+9
+3% +$2.85K 0.06% 214
2022
Q3
$83K Hold
298
0.05% 213
2022
Q2
$79K Hold
298
0.05% 214
2022
Q1
$71K Buy
298
+162
+119% +$37.9K 0.04% 241
2021
Q4
$31K Hold
136
0.02% 285
2021
Q3
$27K Hold
136
0.02% 234
2021
Q2
$32K Buy
+136
New +$34K 0.03% 223
2020
Q4
$28K Buy
+136
New +$26.7K 0.03% 226

Other funds holding CI

Addison Advisors's CI Position: Q2 2026 in Review

Addison Advisors reduced its Cigna (CI) stake by 30% in Q2 2026, selling an estimated $57.6K and leaving 466 shares worth $129K. The position accounts for 0.06% of the portfolio, ranked #153.

Addison Advisors first reported a position in CI in Q4 2020 and has held it in 22 quarters since. The position peaked at $304K in Q1 2024. 1,693 funds tracked by Wall St. Rank hold CI as of Q2 2026.

  • Addison Advisors held 466 shares of Cigna worth $129K as of Q2 2026.
  • Addison Advisors sold 204 Cigna shares in Q2 2026, an estimated $57.6K.
  • Cigna made up 0.06% of Addison Advisors's portfolio in Q2 2026, its #153 holding.
  • Addison Advisors first reported a position in Cigna in Q4 2020 and has held it in 22 quarters since.
  • Addison Advisors's Cigna position peaked at $304K in Q1 2024.
  • 1,693 funds tracked by Wall St. Rank held Cigna as of Q2 2026.

Based on Addison Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.